Download presentation
Presentation is loading. Please wait.
1
Clinical Microbiology and Infection
Oral presentations Clinical Microbiology and Infection Volume 17, Pages S1-S107 (May 2011) DOI: /j x Copyright © Terms and Conditions
2
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
3
Figure 1 In vivo activity of ClyS ointment vs. placebo or mupirocin on tape-stripped mice infected with S. aureus 8325–4 or MRSA MW2. Topical treatrnents included Aquaphor® (control), 10% ClyS binding domain in Aquaphor® (placebo), 10% wt/wt ClyS in Aquaphor®, and 2% mupirocin. The median value of the data for each group is shown as a horizontal bar; each sphere represents one mouse. No statistical significance was seen between untreated, control, and placebo groups. Statistical significance (p < ) was noted between untreated/control/placebo and ClyS groups with a three log drop in bacteria recovered (CFUs). Statistical difference (p = 0.001) was noted between ClyS and mupirocin treated groups, with a one log drop difference between them. Figure is representative of experiments using S. aureus strain 8325–4 or MRSA strain MW2. Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
4
Fig. 1 Percent of cultures from the five high touch sites that were negative for aerobic growth after decontamination with the HPV and UVC process. Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
5
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
6
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
7
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
8
Figure 1 Implementation of policy elements covered by the survey questionnai re Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
9
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
10
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
11
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
12
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
13
Figure 1 Pneumococcal vaccination and invasive pneumococcal disease 2002–2009. Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
14
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
15
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
16
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
17
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
18
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
19
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
20
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
21
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
22
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
23
Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection , S1-S107DOI: ( /j x) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.